tiprankstipranks
Trending News
More News >
Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY

Compare Alnylam Pharma (ALNY) vs. Competitors

Compare
1,381 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Alnylam Pharma
$351.96
$46.50B
1,464.06
29.87%
14 Buy
3 Hold
0 Sell
Strong Buy
Incyte
$102.60
$20.14B
17.21
38.42%
7 Buy
8 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$470.52
$119.38B
33.16
-2.44%
20 Buy
3 Hold
0 Sell
Strong Buy
Argenx Se
$850.87
$52.42B
39.97
30.64%
14 Buy
3 Hold
0 Sell
Strong Buy
Genmab
$31.90
$19.53B
13.44
66.06%
5 Buy
2 Hold
0 Sell
Moderate Buy
BioNTech SE
$108.77
$26.15B
-41.37
-7.15%
12 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ALNY
Alnylam Pharma
351.96
73.71
26.49%
INCY
Incyte
102.60
27.65
36.89%
VRTX
Vertex Pharmaceuticals
470.52
-10.64
-2.21%
ARGX
Argenx Se
850.87
192.90
29.32%
GMAB
Genmab
31.90
12.55
64.86%
BNTX
BioNTech SE
108.77
-11.17
-9.31%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts